Affymax(R) Announces Self-Imposed Quiet Period as the Company Analyzes Phase 3 ... - MarketWatch (press release) PDF Print
MarketWatch (press release)Phase 3 clinical trials investigated the potential for Hematide to treat anemia associated with chronic renal failure. The product, upon approval,

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.